ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 201873 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 201873; 2) Community: the network communities that were significantly associated with the response to NSC 201873; 3) Molecule: the relationships between components within communities and NSC 201873; 4) MDR: the compounds that were significantly associated with the NSC 201873.

NSC Compound Enrichment Correlation
NSC 750050 Null 0.0329129886465387 0.41143492
NSC 753456 2-4-[5-(3,5-dimethoxyphenyl)-1H-1-imidazolyl]phenyl-5,6,7-trimethoxy-1,3-benzothiazole 0.0329129886465387 0.36111555
NSC 758670 TANNIC ACID 0.0329129886465387 0.24947047
NSC 762901 trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide 0.0329129886465387 0.28759673
NSC 762908 2-(4-(methylsulfonyl)phenyl)-6-p-tolyl-4,5-dihydropyridazin-3(2H)-one 0.0329129886465387 0.40737732
NSC 169434 component of Monistat cream 0.0329129886465389 -0.0093882715
NSC 102051 Null 0.0375780807984386 -0.08308144
NSC 15795 Null 0.0375780807984386 0.2657063
NSC 176328 Ellipticine, 6-(3-aminopropyl)-, dihydrochloride 0.0375780807984386 0.42413075
NSC 339705 5H-Indeno[1,2-c]isoquinoline-5,11(6H)-dione, 6-(2-hydroxyethyl)- 0.0375780807984386 0.11776533
Total:67  Current:47    [First] [Prev] [Next] [Last]